New genome editing technology "CRISPR-Cas3 system"
About the new genome editing technology 'CRISPR-Cas3'
CRISPR-Cas3 is a genome editing technology developed in Japan based on the research results of Professor Tomoshige Mukaida from the Advanced Animal Genome Research Division at the University of Tokyo Institute of Medical Science, and Professor Junji Takeda from the Osaka University Graduate School of Microbiology. CRISPR-Cas3 has the characteristic of inducing large deletions by continuously cutting the genome, and it also has a very low impact from off-target effects. Recently, Nippon Gene Co., Ltd. has entered into a licensing agreement with C4U Co., Ltd. regarding CRISPR-Cas3 technology and has begun supplying high-purity Cas3 protein and Cascade-crRNA complexes. 【Features of the CRISPR-Cas3 System】 - Large-scale deletions of the genome are possible - Low risk of off-target mutations and high specificity (a highly safe genome editing technology) - Simple licensing makes it easier to establish strategies for the practical application of genome editing technology *For more details, please refer to the catalog.
- 企業：ニッポンジーン
- 価格：Other
![[Research Material] The Global Market for Gene Editing](https://image.mono.ipros.com/public/product/image/94f/2001471799/IPROS88081586922359158793.jpeg?w=280&h=280)
